Notably, recent research found that plasma levels of HMGB1 significantly increased in tPA-treated ischemic stroke patients, and HMGB1-triggered neuroinflammation aggravated tPA-mediated HT in a rat model of ischemic stroke [21, 22]. Here, HMGB1 is linked to hematocrit.